CA2547824A1 - Evaluation des risques de cancer colono-rectal - Google Patents
Evaluation des risques de cancer colono-rectal Download PDFInfo
- Publication number
- CA2547824A1 CA2547824A1 CA002547824A CA2547824A CA2547824A1 CA 2547824 A1 CA2547824 A1 CA 2547824A1 CA 002547824 A CA002547824 A CA 002547824A CA 2547824 A CA2547824 A CA 2547824A CA 2547824 A1 CA2547824 A1 CA 2547824A1
- Authority
- CA
- Canada
- Prior art keywords
- base
- human chromosome
- increased risk
- linkage therewith
- strong disequilibrium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Ecology (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002547824A CA2547824A1 (fr) | 2006-06-05 | 2006-06-05 | Evaluation des risques de cancer colono-rectal |
PCT/CA2007/000993 WO2007140599A1 (fr) | 2006-06-05 | 2007-06-05 | Évaluation de risque pour cancer colorectal |
CA002654165A CA2654165A1 (fr) | 2006-06-05 | 2007-06-05 | Evaluation de risque pour cancer colorectal |
US12/303,410 US8153369B2 (en) | 2006-06-05 | 2007-06-05 | Assessment of risk for colorectal cancer |
AU2007257162A AU2007257162A1 (en) | 2006-06-05 | 2007-06-05 | Assessment of risk for colorectal cancer |
EP07719909A EP2035439A4 (fr) | 2006-06-05 | 2007-06-05 | Évaluation de risque pour cancer colorectal |
EP10007610A EP2236623A1 (fr) | 2006-06-05 | 2007-06-05 | Evaluation du risque dans le cancer colorectal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002547824A CA2547824A1 (fr) | 2006-06-05 | 2006-06-05 | Evaluation des risques de cancer colono-rectal |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2547824A1 true CA2547824A1 (fr) | 2007-12-05 |
Family
ID=38792271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002547824A Abandoned CA2547824A1 (fr) | 2006-06-05 | 2006-06-05 | Evaluation des risques de cancer colono-rectal |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2547824A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115820845A (zh) * | 2022-07-02 | 2023-03-21 | 武汉大学 | 一种与结直肠癌诊断相关的多聚腺苷酸化功能位点标记及其应用 |
CN115963268A (zh) * | 2023-02-14 | 2023-04-14 | 浙江大学 | 一种用于结直肠癌早期诊断的血浆分泌蛋白组合及应用 |
WO2023226939A1 (fr) * | 2022-05-25 | 2023-11-30 | 广州市基准医疗有限责任公司 | Biomarqueur de méthylation pour détecter les métastases des ganglions lymphatiques dans le cancer colorectal et son utilisation |
-
2006
- 2006-06-05 CA CA002547824A patent/CA2547824A1/fr not_active Abandoned
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023226939A1 (fr) * | 2022-05-25 | 2023-11-30 | 广州市基准医疗有限责任公司 | Biomarqueur de méthylation pour détecter les métastases des ganglions lymphatiques dans le cancer colorectal et son utilisation |
CN115820845A (zh) * | 2022-07-02 | 2023-03-21 | 武汉大学 | 一种与结直肠癌诊断相关的多聚腺苷酸化功能位点标记及其应用 |
CN115963268A (zh) * | 2023-02-14 | 2023-04-14 | 浙江大学 | 一种用于结直肠癌早期诊断的血浆分泌蛋白组合及应用 |
CN115963268B (zh) * | 2023-02-14 | 2023-09-19 | 浙江大学 | 一种用于结直肠癌早期诊断的血浆分泌蛋白组合及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110189663A1 (en) | Assessment of risk for colorectal cancer | |
US20090317816A1 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
US8153369B2 (en) | Assessment of risk for colorectal cancer | |
US8114592B2 (en) | Genetic markers associated with age-related macular degeneration, methods of detection and uses thereof | |
US20050064440A1 (en) | Methods for identifying risk of melanoma and treatments thereof | |
CA2561742A1 (fr) | Procedes d'identification de risque d'osteoarthrite et traitements associes | |
US20050277118A1 (en) | Methods for identifying subjects at risk of melanoma and treatments thereof | |
CA2547824A1 (fr) | Evaluation des risques de cancer colono-rectal | |
US20050064442A1 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
CA2579588A1 (fr) | Evaluation du risque de cancer colono-rectal | |
CA2548375A1 (fr) | Evaluation du risque de cancer colono-rectal | |
WO2009050507A1 (fr) | Marqueurs pour le cancer colorectal | |
CA2567973A1 (fr) | Procedes pour identifier un risque de cancer du sein et traitements associes | |
US20050118606A1 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
EP2112229A2 (fr) | Procédés d'identification du risque du cancer du sein et traitements associés |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |